11. Influence of cerium triflate and glycerol on electrochemical performance of chitosan electrolytes for electrochromic devices. (1st November 2016) Authors: Alves, R.; Sentanin, F.; Sabadini, R.C.; Pawlicka, A.; Silva, M.M. Journal: Electrochimica acta Issue: Volume 217(2016) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Modeling and simulation of a beet pulp dryer for a training simulator. Issue 14 (22nd September 2017) Authors: Merino, A.; Alves, R.; Acebes, L. F.; Prada, C. Journal: Drying technology Issue: Volume 35:Issue 14(2017) Page Start: 1765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Modeling and simulation of a beet pulp dryer for a training simulator. Issue 14 (3rd October 2017) Authors: Merino, A.; Alves, R.; Acebes, L. F.; Prada, C. Journal: Drying technology Issue: Volume 35:Issue 14(2017) Page Start: 1765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. PB1781: THERAPEUTIC POTENTIAL OF DNA DAMAGE RESPONSE IN ACUTE MYELOBLASTIC LEUKEMIA. (23rd June 2022) Authors: Lapa, B.; Costa, M. I.; Jorge, J.; Alves, R.; Sarmento-Ribeiro, A. B.; Gonçalves, A. C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. PB1782: ZINC IN THE MODULATION OF THE ANTIPROLIFERATIVE AND CYTOTOXIC EFFECTS OF OLAPARIB IN ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Costa, M. I.; Lapa, B.; Jorge, J.; Alves, R.; Sarmento-Ribeiro, A. B.; Gonçalves, A. C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. PB1856: DEMETHYLATING AGENTS AND HISTONE DEACETYLASE INHIBITORS AS NEW THERAPEUTIC STRATEGIES IN CHRONIC LYMPHOCYTIC LEUKEMIA. (23rd June 2022) Authors: Jorge #, J.; Gaspar #, T.; Costa, M. I.; Lapa, B.; Alves, R.; Gonçalves, A. C.; Sarmento-Ribeiro, A. B. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH. (23rd June 2022) Authors: Carda #, J. P.; Gomes #, R.; Jorge, J.; Gonçalves, A. C.; Marques, B.; Alves, R.; Sarmento-Ribeiro, A. B. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome. (1st July 2016) Authors: Child, F.; Ortiz‐Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; Weichenthal, M.; Alves, R.; Quaglino, P.; Beylot‐Barry, M.; Cowan, R.; Geskin, L.J.; Pérez‐Ferriols, A.; Hellemans, P.; Elsayed, Y.; Phelps, C.; Forslund, A.; Kamida, M.; Zinzani, P.L. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome. (2nd June 2016) Authors: Child, F.; Ortiz‐Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; Weichenthal, M.; Alves, R.; Quaglino, P.; Beylot‐Barry, M.; Cowan, R.; Geskin, L.J.; Pérez‐Ferriols, A.; Hellemans, P.; Elsayed, Y.; Phelps, C.; Forslund, A.; Kamida, M.; Zinzani, P.L. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome3. (2nd June 2016) Authors: Child, F.; Ortiz‐Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; Weichenthal, M.; Alves, R.; Quaglino, P.; Beylot‐Barry, M.; Cowan, R.; Geskin, L.J.; Pérez‐Ferriols, A.; Hellemans, P.; Elsayed, Y.; Phelps, C.; Forslund, A.; Kamida, M.; Zinzani, P.L. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗